136 related articles for article (PubMed ID: 8316003)
21. Case 40. Misdiagnosis of refractory macrocytic anemia.
Stringaris K; Bain B
Leuk Lymphoma; 2008 Nov; 49(11):2196-7. PubMed ID: 19021064
[TBL] [Abstract][Full Text] [Related]
22. [Hematological characteristics of hypoplastic MDS patients with chromosomal abnormalities, who had been followed for aplastic anemia with normal karyotypes].
Tamai Y; Takami H; Nakahata R; Nakui Y; Suzuki Y; Akagi T; Kariya K; Tsushima K; Munakata A; Kawamura S
Rinsho Ketsueki; 1997 Dec; 38(12):1243-8. PubMed ID: 9455142
[TBL] [Abstract][Full Text] [Related]
23. The myelodysplastic syndromes.
Nguyen PL
Hematol Oncol Clin North Am; 2009 Aug; 23(4):675-91. PubMed ID: 19577164
[TBL] [Abstract][Full Text] [Related]
24. Pathogenesis, biology, and management of myelodysplastic syndromes in children.
Haas OA; Gadner H
Semin Hematol; 1996 Jul; 33(3):225-35. PubMed ID: 8819232
[No Abstract] [Full Text] [Related]
25. Long-term survivors of refractory myelodysplastic anemias.
Yoshida Y; Oguma S; Uchino H; Maekawa T; Nomura T
N Engl J Med; 1991 Aug; 325(9):662. PubMed ID: 1861705
[No Abstract] [Full Text] [Related]
26. Familial myelodysplastic syndromes.
Adhikari MR; Pereira P; Ramapuram JT
J Assoc Physicians India; 2000 Mar; 48(3):349-50. PubMed ID: 11229126
[No Abstract] [Full Text] [Related]
27. Serial determination of FLT3 mutations in myelodysplastic syndrome patients at diagnosis, follow up or acute myeloid leukaemia transformation: incidence and their prognostic significance.
Georgiou G; Karali V; Zouvelou C; Kyriakou E; Dimou M; Chrisochoou S; Greka P; Dufexis D; Vervesou E; Dimitriadou E; Efthymiou A; Petrikkos L; Dima K; Lilakos K; Panayiotidis P
Br J Haematol; 2006 Aug; 134(3):302-6. PubMed ID: 16787503
[TBL] [Abstract][Full Text] [Related]
28. [Myelodysplastic syndromes].
Obradov S; Dugumović Z; Nikolić-Bartl J
Med Arh; 1988; 42(4):167-76. PubMed ID: 3270759
[No Abstract] [Full Text] [Related]
29. Myelodysplastic syndromes in patients under 50 years old: a single institution experience.
Breccia M; Mengarelli A; Mancini M; Biondo F; Gentilini F; Latagliata R; Mandelli F; Alimena G
Leuk Res; 2005 Jul; 29(7):749-54. PubMed ID: 15927670
[TBL] [Abstract][Full Text] [Related]
30. Prognostic factors in myelodysplastic and myeloproliferative types of chronic myelomonocytic leukemia: a retrospective analysis of 83 patients from a single institution.
Breccia M; Latagliata R; Mengarelli A; Biondo F; Mandelli F; Alimena G
Haematologica; 2004 Jul; 89(7):866-8. PubMed ID: 15257942
[TBL] [Abstract][Full Text] [Related]
31. Prognostic significance of deletion of the long arm of chromosome 20 in patients with myelodysplastic syndrome (MDS): a study of the Greek MDS Study Group.
Galanopoulos AG; Symeonidis A; Kourakli A; Papadaki EA; Tsaftaridis P; Terpos E; Aktipi A; Roussou P; Protopappa M; Pappaioannou M; Zikos P; Speletas M; Parcharidou A; Laoutaris N; Anagnostopoulos NI; Meletis J; Pangalis GA; Zoumbos N; Viniou N;
Eur J Haematol; 2007 Jan; 78(1):89-90. PubMed ID: 17302860
[No Abstract] [Full Text] [Related]
32. Clinical and laboratory characteristics of myelodysplastic syndromes.
Gupta C; Francis S
Am Clin Lab; 2002 Oct; 21(8):26-8. PubMed ID: 12440173
[No Abstract] [Full Text] [Related]
33. [Adult primary myelodysplastic syndromes. Report of 36 cases].
Khalifa M; Laatiri MA; Chehata S; Rhaiem K; Gharbi O; Amama W; Ennabli S
Tunis Med; 2003 Apr; 81(4):226-9. PubMed ID: 12848003
[TBL] [Abstract][Full Text] [Related]
34. 73-Year-Old Asymptomatic Woman With Anemia.
Jansson-Knodell C; Collins CS
Mayo Clin Proc; 2017 Jun; 92(6):e89-e93. PubMed ID: 28499511
[No Abstract] [Full Text] [Related]
35. Characterization of myelodysplastic syndrome and aplastic anemia by immunostaining of p53 and hemoglobin F and karyotype analysis: differential diagnosis between refractory anemia and aplastic anemia.
Iwasaki T; Murakami M; Sugisaki C; Sobue S; Ohashi H; Asano H; Suzuki M; Nakamura S; Ito M; Murate T
Pathol Int; 2008 Jun; 58(6):353-60. PubMed ID: 18477214
[TBL] [Abstract][Full Text] [Related]
36. [ Myelodysplastic syndrome].
Fenaux P
Rev Prat; 2002 Dec; 52(20):2301-8. PubMed ID: 12621953
[No Abstract] [Full Text] [Related]
37. Cell Population Data NE-WX, NE-FSC, LY-Y of Sysmex XN-9000 can provide additional information to differentiate macrocytic anaemia from myelodysplastic syndrome: A preliminary study.
Di Luise D; Giannotta JA; Ammirabile M; De Zordi V; Torricelli S; Bottalico S; Chiaretto ML; Fattizzo B; Migliorini AC; Ceriotti F
Int J Lab Hematol; 2022 Feb; 44(1):e40-e43. PubMed ID: 34491625
[No Abstract] [Full Text] [Related]
38. [Myelodysplastic syndromes. Case contributions and review of the literature].
Pasqualetti P
G Clin Med; 1987 May; 68(5):281-7. PubMed ID: 3622994
[No Abstract] [Full Text] [Related]
39. Copper deficiency: an important consideration in the differential diagnosis of myelodysplastic syndrome.
Fong T; Vij R; Vijayan A; DiPersio J; Blinder M
Haematologica; 2007 Oct; 92(10):1429-30. PubMed ID: 18024379
[TBL] [Abstract][Full Text] [Related]
40. Myelodysplastic syndromes: a community hospital-based study of prognostic factors and International Prognostic Scoring System.
Mirza I; Garzón R; Burns J; Edwards L; Fernandez-Cymering C; Kloss R
Conn Med; 2001 Aug; 65(8):455-63. PubMed ID: 11550445
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
